Based on the present study findings, the Interleukin 6, is one of the powerful predictors of coronaryartery disease in patients with type 2 diabetes mellitus, since these values are significantly increased in later stages of T2DM and CADwhen compared to newly diagnosed CAD patients. This evidence concerns the gene IL6 and coronary artery disorder.